- Home
- BCYC vs AGS Comparison
BCYC vs AGS Comparison
Compare BCYC & AGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- AGS
- Stock Information
- Founded
- BCYC 2009
- AGS 2005
- Country
- BCYC United Kingdom
- AGS United States
- Employees
- BCYC N/A
- AGS N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- AGS Miscellaneous manufacturing industries
- Sector
- BCYC Health Care
- AGS Consumer Discretionary
- Exchange
- BCYC Nasdaq
- AGS Nasdaq
- Market Cap
- BCYC 566.5M
- AGS 508.0M
- IPO Year
- BCYC 2019
- AGS 2018
- Fundamental
- Price
- BCYC $7.42
- AGS $12.38
- Analyst Decision
- BCYC Buy
- AGS Hold
- Analyst Count
- BCYC 10
- AGS 1
- Target Price
- BCYC $25.00
- AGS $12.50
- AVG Volume (30 Days)
- BCYC 223.0K
- AGS 411.9K
- Earning Date
- BCYC 08-05-2025
- AGS 08-06-2025
- Dividend Yield
- BCYC N/A
- AGS N/A
- EPS Growth
- BCYC N/A
- AGS 852.53
- EPS
- BCYC N/A
- AGS 1.16
- Revenue
- BCYC $25,722,000.00
- AGS $393,717,000.00
- Revenue This Year
- BCYC $7.35
- AGS $4.30
- Revenue Next Year
- BCYC N/A
- AGS $5.14
- P/E Ratio
- BCYC N/A
- AGS $10.70
- Revenue Growth
- BCYC N/A
- AGS 6.60
- 52 Week Low
- BCYC $6.10
- AGS $11.09
- 52 Week High
- BCYC $28.67
- AGS $12.41
- Technical
- Relative Strength Index (RSI)
- BCYC 36.14
- AGS 67.73
- Support Level
- BCYC $8.33
- AGS $12.36
- Resistance Level
- BCYC $8.63
- AGS $12.40
- Average True Range (ATR)
- BCYC 0.50
- AGS 0.04
- MACD
- BCYC -0.13
- AGS -0.00
- Stochastic Oscillator
- BCYC 7.18
- AGS 86.05
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About AGS PlayAGS Inc.
PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.